{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T20:15:06Z","timestamp":1793218506139,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:00:00Z","timestamp":1643155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:00:00Z","timestamp":1643155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["023.016.048]."],"award-info":[{"award-number":["023.016.048]."]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Living with untreated prostate cancer (PCa) may cause anxiety and uncertainty in men undergoing active surveillance (AS). Developing a psychosocial support program for such patients might promote psychosocial well-being and patient engagement. This review aims to identify interventions with the potential to influence the psychosocial burden of prostate cancer patients undergoing AS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A scoping review was conducted in accordance with the PRISMA Extension for Scoping Reviews Checklist. A systematic search was conducted in six databases and included publications dating from 2009. All available and eligible evidence was included in this review.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>After screening 2824 articles, 12 studies were included in the review: nine quantitative, one qualitative, and two mixed method papers. The relative strength of these studies was limited and the quality of most was moderate.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The described interventions can be categorized into three major themes: information and education, coping and (psycho)social support, and lifestyle. Psychosocial support for men undergoing AS should entail involvement of family and spouse during the decision-making process, tailored information about PCa treatments, risks, benefits, protocols, lifestyle adjustments, and complementary and alternative medicine. Assessment and promotion of effective coping and self-management strategies are recommended. Healthcare providers should actively promote physical activity and nutritional improvements. Physical activity programs may also be helpful in facilitating peer support, which is especially important for men with limited social support. Future research should investigate combining interventions to increase efficacy and optimize supportive care during AS.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00520-022-06830-z","type":"journal-article","created":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T18:02:38Z","timestamp":1643220158000},"page":"4699-4709","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["What interventions affect the psychosocial burden experienced by prostate cancer patients undergoing active surveillance? A scoping review"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7367-2348","authenticated-orcid":false,"given":"Kim","family":"Donachie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Cornel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Pelgrim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Michielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Langenveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Adriaansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Lechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,26]]},"reference":[{"issue":"3","key":"6830_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"6830_CR2","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1200\/JCO.2004.10.062","volume":"22","author":"M Cooperberg","year":"2004","unstructured":"Cooperberg M, Lubeck D, Meng M, Mehta S, Carroll P (2004) The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol 22(11):2141\u20132149","journal-title":"J Clin Oncol"},{"issue":"4","key":"6830_CR3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.urolonc.2017.10.003","volume":"36","author":"E Serrell","year":"2018","unstructured":"Serrell E, Pitts D, Hayn M, Beaule L, Hansen M, Sammon J (2018) Review of the comparative effectiveness of radical prostatectomy, radiation therapy, or expectant management of localized prostate cancer in registry data. Urol Oncol 36(4):183\u2013192","journal-title":"Urol Oncol"},{"issue":"4","key":"6830_CR4","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3322\/caac.21278","volume":"65","author":"C Filson","year":"2015","unstructured":"Filson C, Marks L, Litwin M (2015) Expectant management for men with early stage prostate cancer. CA Cancer J Clin 65(4):264\u2013282","journal-title":"CA Cancer J Clin"},{"key":"6830_CR5","doi-asserted-by":"crossref","unstructured":"Mottet N, van den Bergh RC, Briers E, Van den Broeck T, Cumberbatch MG, De Santis M. et al (2021) EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer\u20142020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Euro Urol 79(2):243\u2013262","DOI":"10.1016\/j.eururo.2020.09.042"},{"issue":"14","key":"6830_CR6","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1002\/cncr.26688","volume":"118","author":"K Keegan","year":"2011","unstructured":"Keegan K, Dall\u2019Era M, Durbin-Johnson B, Evans C (2011) Active surveillance for prostate cancer compared with immediate treatment. Cancer 118(14):3512\u20133518","journal-title":"Cancer"},{"key":"6830_CR7","doi-asserted-by":"crossref","unstructured":"Hamdy F, Donovan J, Lane J, Mason M, Metcalfe C, Holding P et al (2020) Activemonitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT. Health Technology Assessment (Winchester, England), 24(37):1","DOI":"10.3310\/hta24370"},{"issue":"21","key":"6830_CR8","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1001\/jama.2010.1720","volume":"304","author":"J Hayes","year":"2010","unstructured":"Hayes J, Ollendorf D, Pearson S, Barry M, Kantoff P, Stewart S et al (2010) Active surveillance compared with initial treatment for men with low-risk prostate cancer. JAMA 304(21):2373","journal-title":"JAMA"},{"issue":"3","key":"6830_CR9","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/j.1464-410X.2007.06981.x","volume":"100","author":"T Pickles","year":"2007","unstructured":"Pickles T, Ruether J, Weir L, Carlson L, Jakulj F (2007) Psychosocial barriers to active surveillance for the management of early prostate cancer and a strategy for increased acceptance. BJU Int 100(3):544\u2013551","journal-title":"BJU Int"},{"issue":"3","key":"6830_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.eururo.2018.02.026","volume":"74","author":"N Kinsella","year":"2018","unstructured":"Kinsella N, Stattin P, Cahill D, Brown C, Bill-Axelson A, Bratt O et al (2018) Factors influencing men\u2019s choice of and adherence to active surveillance for low-risk prostate cancer: a mixed-method systematic review. Eur Urol 74(3):261\u2013280","journal-title":"Eur Urol"},{"issue":"6","key":"6830_CR11","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.juro.2018.06.013","volume":"200","author":"K Marzouk","year":"2018","unstructured":"Marzouk K, Assel M, Ehdaie B, Vickers A (2018) Long-term cancer specific anxiety in men undergoing active surveillance of prostate cancer: findings from a large prospective cohort. J Urol 200(6):1250\u20131255","journal-title":"J Urol"},{"key":"6830_CR12","doi-asserted-by":"crossref","unstructured":"Venderbos LD, Van Den Bergh RC, Roobol MJ, Schr\u00f6der FH, Essink-Bot ML, Bangma CH, \u2026, Korfage IJ (2015) A longitudinal study on the impact of active surveillance for prostate cancer on anxiety and distress levels. Psychooncology 24(3):348-354","DOI":"10.1002\/pon.3657"},{"issue":"3","key":"6830_CR13","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/MOU.0000000000000157","volume":"25","author":"P Albertsen","year":"2015","unstructured":"Albertsen P (2015) Observational studies and the natural history of screen-detected prostate cancer. Curr Opin Urol 25(3):232\u2013237","journal-title":"Curr Opin Urol"},{"issue":"3","key":"6830_CR14","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/bju.13099","volume":"117","author":"P Parker","year":"2015","unstructured":"Parker P, Davis J, Latini D, Baum G, Wang X, Ward J et al (2015) Relationship between illness uncertainty, anxiety, fear of progression and quality of life in men with favourable-risk prostate cancer undergoing active surveillance. BJU Int 117(3):469\u2013477","journal-title":"BJU Int"},{"key":"6830_CR15","doi-asserted-by":"crossref","unstructured":"Cheah WL, Ling NC, Chang KH (2016) The supportive care needs for prostate cancer patients in Sarawak. Chinese Clinical Oncol 5(1):7\u20137","DOI":"10.1155\/2016\/7297813"},{"issue":"1","key":"6830_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2190\/EUFN-RV1K-Y3TR-FK0L","volume":"36","author":"R Osborn","year":"2006","unstructured":"Osborn R, Demoncada A, Feuerstein M (2006) Psychosocial interventions for depression, anxiety, and quality of life in cancer survivors: meta-analyses. Int J Psychiatry Med 36(1):13\u201334","journal-title":"Int J Psychiatry Med"},{"issue":"2","key":"6830_CR17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/bju.12989","volume":"116","author":"K Parahoo","year":"2015","unstructured":"Parahoo K, McDonough S, McCaughan E, Noyes J, Semple C, Halstead E et al (2015) Psychosocial interventions for men with prostate cancer: a Cochrane systematic review. BJU Int 116(2):174\u2013183","journal-title":"BJU Int"},{"issue":"3","key":"6830_CR18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/ijun.12242","volume":"14","author":"K Donachie","year":"2020","unstructured":"Donachie K, Cornel E, Adriaansen M, Mennes R, Oort I, Bakker E et al (2020) Optimizing psychosocial support in prostate cancer patients during active surveillance. Int J Urol Nurs 14(3):115\u2013123","journal-title":"Int J Urol Nurs"},{"issue":"7","key":"6830_CR19","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"A Tricco","year":"2018","unstructured":"Tricco A, Lillie E, Zarin W, O\u2019Brien K, Colquhoun H, Levac D et al (2018) PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 169(7):467\u2013473","journal-title":"Ann Intern Med"},{"key":"6830_CR20","doi-asserted-by":"crossref","unstructured":"Munn Z, Peters M, Stern C, Tufanaru C, McArthur A, Aromataris E (2018) Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol\u00a018(1):1\u20137","DOI":"10.1186\/s12874-018-0611-x"},{"issue":"1","key":"6830_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/2327-6924.12380","volume":"29","author":"J Peterson","year":"2017","unstructured":"Peterson J, Pearce P, Ferguson L, Langford C (2017) Understanding scoping reviews. J Am Assoc Nurse Pract 29(1):12\u201316","journal-title":"J Am Assoc Nurse Pract"},{"key":"6830_CR22","doi-asserted-by":"crossref","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev\u00a05(1):1\u201310","DOI":"10.1186\/s13643-016-0384-4"},{"key":"6830_CR23","doi-asserted-by":"crossref","unstructured":"Bramer W, Giustini D, De Jonge G, Holland L, Bekhuis T (2016) De-duplication of database search results for systematic reviews in EndNote. J Med Libr Assoc\u00a0104(3): 240","DOI":"10.3163\/1536-5050.104.3.014"},{"issue":"6","key":"6830_CR24","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1188\/04.ONF.1057-1066","volume":"31","author":"M Wallace","year":"2004","unstructured":"Wallace M, Bailey D, O\u2019Rourke M, Galbraith M (2004) The watchful waiting management option for older men with prostate cancer: state of the science. Oncol Nurs Forum 31(6):1057\u20131066","journal-title":"Oncol Nurs Forum"},{"issue":"1","key":"6830_CR25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1464-410X.2008.07585.x","volume":"102","author":"J Adolfsson","year":"2008","unstructured":"Adolfsson J (2008) Watchful waiting and active surveillance: the current position. BJU Int 102(1):10\u201314","journal-title":"BJU Int"},{"key":"6830_CR26","unstructured":"Law M, Stewart D, Letts L, Pollock N, Bosch J, Westmorland M (1998) Guidelines for critical review of qualitative studies. McMaster University occupational therapy evidence-based practice research Group, 1\u20139"},{"key":"6830_CR27","doi-asserted-by":"crossref","unstructured":"Hong QN, F\u00e0bregues S, Bartlett G, Boardman F, Cargo M, Dagenais P. et al (2018) The mixed methods appraisal tool (MMAT) version 2018 for information professionals and researchers. Educ Info 34(4):285\u2013291","DOI":"10.3233\/EFI-180221"},{"issue":"6","key":"6830_CR28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J (2007) Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care 19(6):349\u2013357","journal-title":"Int J Qual Health Care"},{"key":"6830_CR29","unstructured":"Melnyk BM, Fineout-Overholt E (eds) (2011) Evidence-based practice in nursing & healthcare: a guide to best practice. Lippincott Williams & Wilkins"},{"issue":"1","key":"6830_CR30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/0091217420938896","volume":"56","author":"N Baba","year":"2021","unstructured":"Baba N, Schrage T, Hartmann A, Baba K, Wuensch A, Schultze-Seemann W, Joos A (2021) Mental distress and need for psychosocial support in prostate cancer patients: an observational cross-sectional study. Int J Psychiatry Med 56(1):51\u201363","journal-title":"Int J Psychiatry Med"},{"key":"6830_CR31","doi-asserted-by":"crossref","unstructured":"Berg CJ, Habibian DJ, Katz AE, Kosinski KE, Corcoran AT, Fontes AS (2016) Active holistic surveillance: the nutritional aspect of delayed intervention in prostate cancer. J Nutr Metab","DOI":"10.1155\/2016\/2917065"},{"key":"6830_CR32","doi-asserted-by":"crossref","unstructured":"Hedden L, Wassersug R, Mahovlich S, Pollock P, Sundar M, Bell RH, \u2026, Higano CS (2017) Evaluating an educational intervention to alleviate distress amongst men with newly diagnosed prostate cancer and their partners. BJU Int 120(5B):E21-E29","DOI":"10.1111\/bju.13885"},{"key":"6830_CR33","doi-asserted-by":"crossref","unstructured":"Kazer MW, Bailey DE, Sanda M, Colberg J, Kelly WK (2011) An internet intervention for management of uncertainty during active surveillance for prostate cancer. In Oncol Nurs Forum 38(5):561\u2013568","DOI":"10.1188\/11.ONF.561-568"},{"key":"6830_CR34","doi-asserted-by":"crossref","unstructured":"Kinsella N, Stattin P, Cahill D, Brown C, Bill-Axelson A, Bratt O, \u2026, Van Hemelrijck M (2018) Factors influencing men\u2019s choice of and adherence to active surveillance for low-risk prostate cancer: a mixed-method systematic review. Eur Urol 74(3):261-280","DOI":"10.1016\/j.eururo.2018.02.026"},{"key":"6830_CR35","doi-asserted-by":"crossref","unstructured":"Kinsella N, Beckmann K, Cahill D, Elhage O, Popert R, Cathcart P, \u2026, Van Hemelrijck M (2019) A single educational seminar increases confidence and decreases dropout from active surveillance by 5 years after diagnosis of prostate cancer. Eur Urol Oncol 2(4):464-470","DOI":"10.1016\/j.euo.2018.09.007"},{"issue":"12","key":"6830_CR36","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1002\/pon.5262","volume":"28","author":"M McIntosh","year":"2019","unstructured":"McIntosh M, Opozda MJ, Evans H, Finlay A, Galv\u00e3o DA, Chambers SK, Short CE (2019) A systematic review of the unmet supportive care needs of men on active surveillance for prostate cancer. Psychooncology 28(12):2307\u20132322","journal-title":"Psychooncology"},{"issue":"4","key":"6830_CR37","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1177\/1049732309332692","volume":"19","author":"JL Oliffe","year":"2009","unstructured":"Oliffe JL, Davison BJ, Pickles T, Mr\u00f3z L (2009) The self-management of uncertainty among men undertaking active surveillance for low-risk prostate cancer. Qual Health Res 19(4):432\u2013443","journal-title":"Qual Health Res"},{"key":"6830_CR38","doi-asserted-by":"crossref","unstructured":"Papadopoulos E, Alibhai SM, Dor\u00e9 I, Matthew AG, Tomlinson GA, Nesbitt M, \u2026, Santa Mina D (2020) Associations between self-reported physical activity, quality of life, and emotional well-being in men with prostate cancer on active surveillance. Psychooncology 29(6):1044-1050","DOI":"10.1002\/pon.5375"},{"key":"6830_CR39","doi-asserted-by":"crossref","unstructured":"Sumiyoshi Y, Hashine K, Kakehi Y, Yoshimura K, Satou T, Kuruma H, \u2026, Shinohara N (2010) Dietary administration of mushroom Mycelium extracts in patients with early stage prostate cancers managed expectantly: a phase II study. Jpn J Clin Oncol 40(10):967-972","DOI":"10.1093\/jjco\/hyq081"},{"issue":"2","key":"6830_CR40","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/pcan.2014.6","volume":"17","author":"R Thomas","year":"2014","unstructured":"Thomas R, Williams M, Sharma H, Chaudry A, Bellamy P (2014) A double-blind, placebo-controlled randomised trial evaluating the effect of a polyphenol-rich whole food supplement on PSA progression in men with prostate cancer\u2014the UK NCRN Pomi-T study. Prostate Cancer Prostatic Dis 17(2):180\u2013186","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"6830_CR41","doi-asserted-by":"crossref","unstructured":"Victorson D, Hankin V, Burns J, Weiland R, Maletich C, Sufrin N, \u2026, Brendler C (2017) Feasibility, acceptability and preliminary psychological benefits of mindfulness meditation training in a sample of men diagnosed with prostate cancer on active surveillance: results from a randomized controlled pilot trial. Psycho\u2010Oncology 26(8):1155-1163","DOI":"10.1002\/pon.4135"},{"key":"6830_CR42","doi-asserted-by":"crossref","unstructured":"Bayliss D (2016) Decision-making in prostate cancer: active surveillance over other Treatment Options. Urol Nurs 36(3)","DOI":"10.7257\/1053-816X.2016.36.3.141"},{"issue":"10","key":"6830_CR43","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1001\/jamaoncol.2016.3600","volume":"3","author":"S Loeb","year":"2017","unstructured":"Loeb S, Folkvaljon Y, Curnyn C, Robinson D, Bratt O, Stattin P (2017) Uptake of active surveillance for very-low-risk prostate cancer in Sweden. JAMA Oncol 3(10):1393\u20131398","journal-title":"JAMA Oncol"},{"issue":"10","key":"6830_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11912-020-00962-3","volume":"22","author":"GE Coll\u00e9e","year":"2020","unstructured":"Coll\u00e9e GE, van der Wilk BJ, van Lanschot JJB, Busschbach JJ, Timmermans L, Lagarde SM, Kranenburg LW (2020) Interventions that facilitate shared decision-making in cancers with active surveillance as treatment option: a systematic review of literature. Curr Oncol Rep 22(10):1\u201313","journal-title":"Curr Oncol Rep"},{"issue":"4","key":"6830_CR45","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.apnr.2009.08.001","volume":"24","author":"DE Bailey Jr","year":"2011","unstructured":"Bailey DE Jr, Wallace M, Latini DM, Hegarty J, Carroll PR, Klein EA, Albertsen PC (2011) Measuring illness uncertainty in men undergoing active surveillance for prostate cancer. Appl Nurs Res 24(4):193\u2013199","journal-title":"Appl Nurs Res"},{"issue":"2","key":"6830_CR46","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/pon.3391","volume":"23","author":"SK Chambers","year":"2014","unstructured":"Chambers SK, Zajdlewicz L, Youlden DR, Holland JC, Dunn J (2014) The validity of the distress thermometer in prostate cancer populations. Psychooncology 23(2):195\u2013203","journal-title":"Psychooncology"},{"issue":"8","key":"6830_CR47","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s11136-009-9516-9","volume":"18","author":"RC van den Bergh","year":"2009","unstructured":"van den Bergh RC, Korfage IJ, Borsboom GJ, Steyerberg EW, Essink-Bot ML (2009) Prostate cancer-specific anxiety in Dutch patients on active surveillance: validation of the memorial anxiety scale for prostate cancer. Qual Life Res 18(8):1061\u20131066","journal-title":"Qual Life Res"},{"issue":"3","key":"6830_CR48","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11864-007-0034-0","volume":"8","author":"SA Kenfield","year":"2007","unstructured":"Kenfield SA, Chang ST, Chan JM (2007) Diet and lifestyle interventions in active surveillance patients with favorable-risk prostate cancer. Curr Treat Options Oncol 8(3):173\u2013196","journal-title":"Curr Treat Options Oncol"},{"key":"6830_CR49","doi-asserted-by":"crossref","unstructured":"Brookman-May SD, Campi R, Henr\u00edquez JD, Klatte T, Langenhuijsen JF, Brausi M, \u2026, Minervini A (2019) Latest evidence on the impact of smoking, sports, and sexual activity as modifiable lifestyle risk factors for prostate cancer incidence, recurrence, and progression: a systematic review of the literature by the European Association of Urology Section of Oncological Urology (ESOU). Eur Urol Focus 5(5):756-787","DOI":"10.1016\/j.euf.2018.02.007"},{"key":"6830_CR50","doi-asserted-by":"crossref","unstructured":"Campbell MK, Carr C, DeVellis B, Switzer B, Biddle A, Amamoo MA, \u2026, Sandler R (2009) A randomized trial of tailoring and motivational interviewing to promote fruit and vegetable consumption for cancer prevention and control. Ann Behav Med 38(2):71-85","DOI":"10.1007\/s12160-009-9140-5"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-06830-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-022-06830-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-06830-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T10:33:16Z","timestamp":1651055596000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-022-06830-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,26]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["6830"],"URL":"https:\/\/doi.org\/10.1007\/s00520-022-06830-z","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,26]]},"assertion":[{"value":"13 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Since this is a review study, no ethical approval is required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}